What is she best known for?
The fields of study she is best known for:
Her scientific interests lie mostly in Methyltransferase, Gene, Genetics, Biochemistry and Cancer research.
Her studies in Methyltransferase integrate themes in fields like Histone H3 and Epigenetics.
When carried out as part of a general Genetics research project, her work on DNA Methylation Regulation, RNA-Directed DNA Methylation, Epigenomics and Epigenetics of physical exercise is frequently linked to work in Histone code, therefore connecting diverse disciplines of study.
Her research on Biochemistry frequently connects to adjacent areas such as Cell biology.
Her Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Chromatin, Histone and MYST3.
Her Histone research incorporates elements of Acetylation, Human genome and Methyltransferase complex.
Her most cited work include:
- Histone recognition and large-scale structural analysis of the human bromodomain family. (937 citations)
- A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells (375 citations)
- The c-Myc Oncogene Directly Induces the H19 Noncoding RNA by Allele-Specific Binding to Potentiate Tumorigenesis (351 citations)
What are the main themes of her work throughout her whole career to date?
Dalia Barsyte-Lovejoy mainly focuses on Methyltransferase, Biochemistry, Cell biology, Histone and Epigenetics.
Her Methyltransferase study is concerned with the field of Methylation as a whole.
Her research integrates issues of Teneurin, Protein domain, Transcription factor and Messenger RNA in her study of Cell biology.
Her work carried out in the field of Histone brings together such families of science as Chromatin and Function.
Her Epigenetics study combines topics in areas such as Chemical biology, Epigenomics, DNA methylation and Cellular differentiation.
Her Gene study deals with the bigger picture of Genetics.
She most often published in these fields:
- Methyltransferase (47.62%)
- Biochemistry (32.38%)
- Cell biology (42.86%)
What were the highlights of her more recent work (between 2018-2021)?
- Cell biology (42.86%)
- Methyltransferase (47.62%)
- Histone (32.38%)
In recent papers she was focusing on the following fields of study:
Dalia Barsyte-Lovejoy mostly deals with Cell biology, Methyltransferase, Histone, Methylation and Arginine.
Her study in Cell biology is interdisciplinary in nature, drawing from both Chromatin, Protein domain, Gene and Binding domain.
Her study with Methyltransferase involves better knowledge in Biochemistry.
Her research in Histone focuses on subjects like Transcription factor, which are connected to DNA methylation, Gene expression and Acetylation.
The concepts of her Methylation study are interwoven with issues in Cancer, Epigenetics and Computational biology.
Her Epigenetics research incorporates themes from Epigenomics and Drug discovery.
Between 2018 and 2021, her most popular works were:
- Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. (64 citations)
- A chemical biology toolbox to study protein methyltransferases and epigenetic signaling (60 citations)
- A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor (30 citations)
In her most recent research, the most cited papers focused on:
Her primary areas of investigation include Cell biology, Methylation, Methyltransferase, Epigenetics and Arginine.
Her biological study deals with issues like Chromatin, which deal with fields such as In vitro, Protein domain, Myeloid leukemia and Messenger RNA.
Her Methyltransferase study is related to the wider topic of Biochemistry.
Dalia Barsyte-Lovejoy has researched Epigenetics in several fields, including Chemical biology, Histone and Computational biology.
Her work on EZH2 as part of general Histone study is frequently linked to Differentiation therapy, therefore connecting diverse disciplines of science.
Her research integrates issues of Cell, Proteostasis and Proteasome in her study of Arginine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
